Александр Панчин - Сумма биотехнологии. Руководство по борьбе с мифами о генетической модификации растений, животных и людей

369. Tomita H. et al.: Channelrhodopsin-2 gene transduced into retinal ganglion cells restores functional vision in genetically blind rats. Exp Eye Res 2010, 90(3):429–36.

370. Ramirez S. et al.: Creating a false memory in the hippocampus. Science 2013, 341(6144):387–91.

371. Bruegmann T. et al.: Optogenetic control of contractile function in skeletal muscle. Nat Commun 2015, 6:7153.

372. Samson M. et al.: Resistance to HIV-1 infection in caucasian individuals bearing mutant alleles of the CCR-5 chemokine receptor gene. Nature 1996, 382(6593):722–5.

373. Dean M. et al.: Genetic restriction of HIV-1 infection and progression to AIDS by a deletion allele of the CKR5 structural gene. Hemophilia Growth and Development Study, Multicenter AIDS Cohort Study, Multicenter Hemophilia Cohort Study, San Francisco City Cohort, ALIVE Study. Science 1996, 273(5283):1856–62.

374. Hutter G. et al.: Long-term control of HIV by CCR5 Delta32/Delta32 stem-cell transplantation. N Engl J Med 2009, 360(7):692–8.

375. Allers K. et al.: Evidence for the cure of HIV infection by CCR5Delta32/Delta32 stem cell transplantation. Blood 2011, 117(10):2791–9.

376. Tebas P. et al.: Gene editing of CCR5 in autologous CD4 T cells of persons infected with HIV. N Engl J Med 2014, 370(10):901–10.

377. Ebina H. et al.: Harnessing the CRISPR/Cas9 system to disrupt latent HIV-1 provirus. Sci Rep 2013, 3:2510.

378. O’Connell M.R. et al.: Programmable RNA recognition and cleavage by CRISPR/Cas9. Nature 2014, 516(7530):263–6.

379. Foster H. et al.: Genetic therapeutic approaches for Duchenne muscular dystrophy. Hum Gene Ther 2012, 23(7):676–87.

380. Yamamoto H. et al.: NCoR1 is a conserved physiological modulator of muscle mass and oxidative function. Cell 2011, 147(4):827–39.

381. Hedrick P.W.: Virgin birth, genetic variation and inbreeding. Biol Lett 2007, 3(6):715–6.

382. Davis G.K: Cyclical parthenogenesis and viviparity in aphids as evolutionary novelties. J Exp Zool B Mol Dev Evol 2012, 318(6):448–59.

383. Bulletti C. et al.: The artificial womb. Ann NY Acad Sci 2011, 1221:124–8.

384. Devlin B. et al.: The heritability of IQ. Nature 1997, 388(6641): 468–71.

385. Plomin R. et al.: Variability and stability in cognitive abilities are largely genetic later in life. Behav Genet 1994, 24(3):207–15.

386. Spitz E. et al.: Comparative diagnoses of twin zygosity by SSLP variant analysis, questionnaire, and dermatoglyphic analysis. Behav Genet 1996, 26(1):55–63.

387. Karaismailoglu S., Erdem A.: The effects of prenatal sex steroid hormones on sexual differentiation of the brain. J Turk Ger Gynecol Assoc 2013, 14(3):163–7.

388. Zhang S. et al.: Serotonin signaling in the brain of adult female mice is required for sexual preference. Proc Natl Acad Sci USA 2013, 110(24):9968–73.

389. Rogaev E.I. et al.: Genotype analysis identifies the cause of the “royal disease”. Science 2009, 326(5954):817.

390. Miller W. et al.: Sequencing the nuclear genome of the extinct woolly mammoth. Nature 2008, 456(7220):387–90.

391. Baker A.J. et al.: Genomic support for a moa-tinamou clade and adaptive morphological convergence in flightless ratites. Mol Biol Evol 2014, 31(7):1686–96.

392. Prufer K. et al.: The complete genome sequence of a Neanderthal from the Altai Mountains. Nature 2014, 505(7481):43–9.

393. Lynch V. et al.: Elephantid genomes reveal the molecular bases of Woolly Mammoth adaptations to the arctic. BioRxiv 2015.

394. Chesne P. et al.: Cloned rabbits produced by nuclear transfer from adult somatic cells. Nat Biotechnol 2002, 20(4):366–9.

395. Campbell K.H. et al.: Sheep cloned by nuclear transfer from a cultured cell line. Nature 1996, 380(6569):64–6.

396. Чайлахян Л. et al.: Электростимулируемое слияние клеток в клеточной инженерии. Биофизика 1987, 32(5):874–87.

397. Meng L. et al.: Rhesus monkeys produced by nuclear transfer. Biol Reprod 1997, 57(2):454–9.

398. Cozzi J. et al.: Procedures for somatic cell nuclear transfer in the rat. Methods Mol Biol 2010, 597:137–50.

399. Wakayama S. et al.: Production of cloned mice from somatic cells, ES cells, and frozen bodies. Methods Enzymol 2010, 476:151–69.

400. Arat S. et al.: 22 semen and reproductive profiles of cloned anatolian grey cattle. Reprod Fertil Dev 2014, 27(1):103–4.

401. Woods G.L et al.: A mule cloned from fetal cells by nuclear transfer. Science 2003, 301(5636):1063.

402. Galli C. et al.: Somatic cell nuclear transfer in horses. Reprod Domest Anim 2008, 43 Suppl 2:331–7.

403. Shin T. et al.: A cat cloned by nuclear transplantation. Nature 2002, 415(6874):859.

404. Lee B.C. et al.: Dogs cloned from adult somatic cells. Nature 2005, 436(7051):641.

405. Loi P. et al.: Genetic rescue of an endangered mammal by crossspecies nuclear transfer using post-mortem somatic cells. Nat Biotechnol 2001, 19(10):962–4.

406. Vanderwall D.K. et al.: Equine cloning: applications and

outcomes. Reprod Fertil Dev 2006, 18(1–2):91–8.

407. Wakayama S. et al.: Successful serial recloning in the mouse over multiple generations. Cell Stem Cell 2013, 12(3):293–7.

408. French A.J. et al.: Development of human cloned blastocysts following somatic cell nuclear transfer with adult fibroblasts. Stem Cells 2008, 26(2):485–93.

409. Unno N. et al.: Development of an artificial placenta: survival of isolated goat fetuses for three weeks with umbilical arteriovenous extracorporeal membrane oxygenation. Artif Organs 1993, 17(12):996–1003.

410. Kfoury C.: Therapeutic cloning: promises and issues. Mcgill J Med 2007, 10(2):112–20.

411. Nayernia K. et al.: In vitro-differentiated embryonic stem cells give rise to male gametes that can generate offspring mice. Dev Cell 2006, 11(1):125–32.

412. Easley C.A. et al.: Gamete derivation from embryonic stem cells, induced pluripotent stem cells or somatic cell nuclear transfer-derived embryonic stem cells: state of the art. Reprod Fertil Dev 2014, 27(1):89–92.

413. Denton P.W., Garcia J.V.: Novel humanized murine models for HIV research. Curr HIV/AIDS Rep 2009, 6(1):13–9.

414. Espuny-Camacho I. et al.: Pyramidal neurons derived from human pluripotent stem cells integrate efficiently into mouse brain circuits in vivo. Neuron 2013, 77(3):440–56.

415. Strom S.C. et al.: Chimeric mice with humanized liver: tools for the study of drug metabolism, excretion, and toxicity. Methods Mol Biol 2010, 640:491–509.

416. Han X. et al.: Forebrain engraftment by human glial progenitor cells enhances synaptic plasticity and learning in adult mice. Cell Stem Cell 2013, 12(3):342–53.

417. Schwitzgebel E.: Do ethicists steal more books? Philosophical Psychology 2009, 22(6):711–25.

418. Olovnikov A.M.: Telomeres, telomerase, and aging: origin of the theory. Exp Gerontol 1996, 31(4):443–8.

419. Betts D. et al.: Reprogramming of telomerase activity and rebuilding of telomere length in cloned cattle. Proc Natl Acad Sci USA 2001, 98(3):1077–82.

420. Poss K.D. et al.: Heart regeneration in zebrafish. Science 2002, 298(5601):2188–90.

421. Engel F.B. et al.: FGF1/p38 MAP kinase inhibitor therapy induces cardiomyocyte mitosis, reduces scarring, and rescues function after myocardial infarction. Proc Natl Acad Sci USA 2006, 103(42):15546–51.

422. Bedelbaeva K. et al.: Lack of p21 expression links cell cycle control and appendage regeneration in mice. Proc Natl Acad Sci USA 2010, 107(13):5845–50.

423. Murphy S.V., Atala A.: 3D bioprinting of tissues and organs. Nat Biotechnol 2014, 32(8):773–85.

424. Ventola C.L.: Medical Applications for 3D Printing: Current and Projected Uses. P T 2014, 39(10):704–11.

425. Buffenstein R.: Negligible senescence in the longest living rodent, the naked mole-rat: insights from a successfully aging species. J Comp Physiol B 2008, 178(4):439–45.

426. Kim E.B. et al.: Genome sequencing reveals insights into physiology and longevity of the naked mole rat. Nature 2011, 479(7372):223–7.

427. Seluanov A. et al.: Hypersensitivity to contact inhibition provides a clue to cancer resistance of naked mole-rat. Proc Natl Acad Sci USA 2009, 106(46):19352–7.

428. McCay C.M. et al.: The effect of retarded growth upon the length of life span and upon the ultimate body size. 1935. Nutrition 1989, 5(3):155–71; discussion 72.

429. Szafranski K., Mekhail K.: The fine line between lifespan extension and shortening in response to caloric restriction. Nucleus 2014, 5(1):56–65.

430. Mattison J.A. et al.: Impact of caloric restriction on health and survival in rhesus monkeys from the NIA study. Nature 2012, 489(7415):318–21.

431. Carey J.R. et al.: Life history response of Mediterranean fruit flies to dietary restriction. Aging cell 2002, 1(2):140–8.

432. Kasumovic M.M. et al.: Body condition but not dietary restriction prolongs lifespan in a semelparous capital breeder. Biology letters 2009, 5(5):636–8.

433. Cooper T.M. et al.: Effect of caloric restriction on life span of the housefly, Musca domestica. FASEB journal: official publication of the Federation of American Societies for Experimental Biology 2004, 18(13):1591–3.

434. Cava E., Fontana L.: Will calorie restriction work in humans? Aging (Albany NY) 2013, 5(7):507–14.

435. Madeo F. et al.: Can autophagy promote longevity? Nature cell biology 2010, 12(9):842–6.

436. Eisenberg T. et al.: Induction of autophagy by spermidine promotes longevity. Nature cell biology 2009, 11(11):1305–14.

437. Morselli E. et al.: Caloric restriction and resveratrol promote longevity through the Sirtuin-1-dependent induction of autophagy. Cell death & disease 2010, 1:e10.

438. Hansen M. et al.: A role for autophagy in the extension of lifespan by dietary restriction in C. elegans. PLoS genetics 2008, 4(2):e24.

439. Jia K., Levine B.: Autophagy is required for dietary restriction-mediated life span extension in C. elegans. Autophagy 2007, 3(6):597–9.

440. Lum J.J. et al.: Autophagy in metazoans: cell survival in the land of plenty. Nature reviews Molecular cell biology 2005, 6(6):439–48.

441. Ravikumar B. et al.: Inhibition of mTOR induces autophagy and reduces toxicity of polyglutamine expansions in fly and mouse models of Huntington disease. Nature genetics 2004, 36(6):585–95.

442. Beauchamp E.M., Platanias L.C.: The evolution of the TOR pathway and its role in cancer. Oncogene 2013, 32(34):3923–32.

443. Saiki S. et al.: Caffeine induces apoptosis by enhancement of autophagy via PI3K/Akt/mTOR/p70S6K inhibition. Autophagy 2011, 7(2):176–87.

444. Zhou H. et al.: Updates of mTOR inhibitors. Anti-cancer agents in medicinal chemistry 2010, 10(7):571–81.

445. Dowling R.J. et al.: Metformin inhibits mammalian target of rapamycin-dependent translation initiation in breast cancer cells. Cancer Res 2007, 67(22):10804–12.

446. Chin R.M. et al.: The metabolite alpha-ketoglutarate extends lifespan by inhibiting ATP synthase and TOR. Nature 2014.

447. Leontieva O.V. et al.: Weekly administration of rapamycin improves survival and biomarkers in obese male mice on high-fat diet. Aging cell 2014.

448. Fok W.C. et al.: Mice fed rapamycin have an increase in life span associated with major changes in the liver transcriptome. PLOS ONE 2014, 9(1):e83988.

449. Miller R.A. et al.: Rapamycin-mediated lifespan increase in mice is dose and sex dependent and metabolically distinct from dietary restriction. Aging Cell 2014, 13(3):468–77.

450. Harrison D.E. et al.: Rapamycin fed late in life extends lifespan in genetically heterogeneous mice. Nature 2009, 460(7253):392–5.

451. Baur J.A. et al.: Resveratrol improves health and survival of mice on a high-calorie diet. Nature 2006, 444(7117):337–42.

452. Miller R.A. et al.: Rapamycin, but not resveratrol or simvastatin, extends life span of genetically heterogeneous mice. The journals of gerontology Series A, Biological sciences and medical sciences 2011, 66(2):191–201.

453. Elmadhun N.Y. et al.: Alcohol Consumption Mitigates Apoptosis and Mammalian Target of Rapamycin Signaling in Myocardium. Journal of the American College of Surgeons 2014.

454. Foster D.A.: Reduced mortality and moderate alcohol consumption: the phospholipase D-mTOR connection. Cell cycle 2010, 9(7):1291–4.

455. Yu X. et al.: Beneficial and harmful effects of alcohol exposure on Caenorhabditis elegans worms. Biochemical and biophysical research communications 2011, 412(4):757–62.

456. Correia S. et al.: Mechanisms of action of metformin in type 2 diabetes and associated complications: an overview. Mini Rev Med Chem 2008, 8(13):1343–54.

457. Onken B., Driscoll M.: Metformin induces a dietary restriction-like state and the oxidative stress response to extend C. elegans Healthspan via AMPK, LKB1, and SKN-1. PLOS ONE 2010, 5(1):e8758.

458. Martin-Montalvo A. et al.: Metformin improves healthspan and lifespan in mice. Nat Commun 2013, 4:2192.

459. Chin R.M. et al.: The metabolite alpha-ketoglutarate extends lifespan by inhibiting ATP synthase and TOR. Nature 2014, 510(7505):397–401.

460. Bhattacharya R. et al.: Toxicity of alpha-ketoglutarate following 14-days repeated oral administration in Wistar rats. Cellular and molecular biology 2011, 57 Suppl: OL1543–9.

461. Bhattacharya R., Vijayaraghavan R.: Promising role of alpha-ketoglutarate in protecting against the lethal effects of cyanide. Human & experimental toxicology 2002, 21(6):297–303.

462. Bhattacharya R. et al.: Biochemical, oxidative and histological changes caused by sub-acute oral exposure of some synthetic cyanogens in rats: Ameliorative effect of alpha-ketoglutarate. Food and chemical toxicology: an international journal published for the British Industrial Biological Research Association 2014, 67:201–11.

463. Hariharakrishnan J. et al.: Cyanide-induced changes in the levels of neurotransmitters in discrete brain regions of rats and their response to oral treatment with alpha-ketoglutarate. Indian journal of experimental biology 2010, 48(7):731–6.

464. Bienholz A. et al.: Adverse effects of alpha-ketoglutarate/ malate in a rat model of acute kidney injury. American journal of physiology Renal physiology 2012, 303(1):F56–63.

465. Coudray-Lucas C. et al.: Ornithine alpha-ketoglutarate improves wound healing in severe burn patients: a prospective randomized double-blind trial versus isonitrogenous controls. Critical care medicine 2000, 28(6):1772–6.

466. Donati L. et al.: Nutritional and clinical efficacy of ornithine alpha-ketoglutarate in severe burn patients. Clinical nutrition 1999, 18(5):307–11.

467. De Bandt J.P. et al.: A randomized controlled trial of the influence of the mode of enteral ornithine alpha-ketoglutarate administration in burn patients. The Journal of nutrition 1998, 128(3):563–9.

468. Campbell B. et al.: Pharmacokinetics, safety, and effects on exercise performance of L-arginine alpha-ketoglutarate in trained adult men. Nutrition 2006, 22(9):872–81.